chr12-53424411-GC-G
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_020547.3(AMHR2):c.175delC(p.Arg59fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,428 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_020547.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMHR2 | ENST00000257863.9 | c.175delC | p.Arg59fs | frameshift_variant | 2/11 | 1 | NM_020547.3 | ENSP00000257863.3 | ||
AMHR2 | ENST00000379791.7 | c.175delC | p.Arg59fs | frameshift_variant | 2/9 | 1 | ENSP00000369117.3 | |||
AMHR2 | ENST00000550311.5 | c.175delC | p.Arg59fs | frameshift_variant | 2/11 | 1 | ENSP00000446661.1 | |||
AMHR2 | ENST00000553037.1 | n.136delC | non_coding_transcript_exon_variant | 1/2 | 4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461428Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727002
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 07, 2024 | This sequence change creates a premature translational stop signal (p.Arg59Alafs*9) in the AMHR2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AMHR2 are known to be pathogenic (PMID: 8872466, 28094762, 28528332). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with AMHR2-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.